Vidarbha News

Propionic Acidemia Treatment, Diagnosis and Market Report by DelveInsight

 Breaking News
  • No posts were found

Propionic Acidemia Treatment, Diagnosis and Market Report by DelveInsight

August 06
18:20 2021
Propionic Acidemia Treatment, Diagnosis and Market Report by DelveInsight

DelveInsight’s  Propionic Acidemia Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Propionic Acidemia, historical and forecasted epidemiology as well as the Propionic Acidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Propionic Acidemia Overview

Propionic Acidemia is an inherited disorder in which the body is unable to process certain parts of proteins and lipids (fats) properly. It is an autosomal recessive disorder and is classified as an organic acid disorder, which arises due to an abnormal rise in levels of particular acids known as organic acids.


Request free sample copy @


List of regions covered in the report

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


List of companies involved in the report

  • Moderna Tx
  • HemoShear
  • And many others


Propionic Acidemia Market Disease

The DelveInsight Propionic Acidemia market report gives a thorough understanding of Propionic Acidemia by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.


Propionic Acidemia Diagnosis

The Diagnosis relies on the detection of biallelic pathogenic variants in PCCA or PCCB or of deficient PCC enzymatic activity. In individuals with equivocal molecular genetic test results, a combination of enzymatic and molecular diagnostics is necessary.


Propionic Acidemia Treatment

Presently, there is no specific treatment for Propionic Acidemia. Management of the individuals with the disease happens through dietary management and liver transplantation in some cases.


Propionic Acidemia Market Report

Mutation in genes that are involved in the production of propionyl-CoA carboxylase, leads to Propionic Acidemia. These genes are: PCCA gene which encodes information to produce alpha subunit of propionyl-CoA carboxylase, and the PCCB gene which encodes information to produce Beta subunit of propionyl-CoA carboxylase, specifically, the beta subunit of this enzyme.


Propionic Acidemia Market Insights

The current treatment regimens in Propionic Acidemia are focused on managing symptoms and providing support. There is no specific therapy or cure for the disease. The optimal management of patients is best achieved by a team of specialists involved in the care of people which include; Nutritionist, Genetics professional, Developmental specialist, Neurologist, Physical therapist and occupational therapist.


Propionic Acidemia Therapies

Available treatments for PA are unsatisfactory and despite therapy, patients still suffer from severe and invalidating complications and remain at risk of life-threatening metabolic crisis. Delayed diagnosis can become a medical emergency. Therefore, there is a high need for other therapies to be rapidly introduced in the clinics to improve the clinical outcomes of patients with PA.


Propionic Acidemia Market Report Scope

  • The report covers the descriptive overview of Propionic Acidemia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Propionic Acidemia epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Propionic Acidemia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Propionic Acidemia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Propionic Acidemia market


Request free sample copy @


Table of content

1. Key Insights

2. Executive Summary of Propionic Acidemia

3. Competitive Intelligence Analysis for Propionic Acidemia

4. Propionic Acidemia: Market Overview at a Glance

5. Propionic Acidemia: Disease Background and Overview

6. Patient Journey

7. Propionic Acidemia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Propionic Acidemia Treatment

11. Marketed Products

12. Emerging Therapies

13. Propionic Acidemia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Propionic Acidemia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


Propionic Acidemia Market Report Highlights

  • In the coming years, the Propionic Acidemia market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Propionic Acidemia R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition     
  • Major players are involved in developing therapies for Propionic Acidemia. The launch of emerging therapies will significantly impact the Propionic Acidemia market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Propionic Acidemia
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities


Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Propionic Acidemia market
  • To understand the future market competition in the Propionic Acidemia market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Propionic Acidemia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for the Propionic Acidemia market
  • To understand the future market competition in the Propionic Acidemia market


About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.


Contact us

Shruti Thakur

[email protected]

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States